IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $104,600 | -13.5% | 22,989 | +33.8% | 0.00% | -20.0% |
Q2 2023 | $120,947 | +75.1% | 17,180 | +51.9% | 0.01% | +66.7% |
Q1 2023 | $69,092 | -12.7% | 11,308 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $79,156 | -26.7% | 11,308 | 0.0% | 0.00% | -40.0% |
Q3 2022 | $108,000 | -12.9% | 11,308 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $124,000 | -59.5% | 11,308 | +10.6% | 0.01% | -70.6% |
Q1 2020 | $306,000 | +9.7% | 10,222 | +1.5% | 0.02% | +41.7% |
Q4 2019 | $279,000 | +56.7% | 10,075 | +3.2% | 0.01% | +50.0% |
Q3 2019 | $178,000 | -25.5% | 9,767 | 0.0% | 0.01% | -27.3% |
Q2 2019 | $239,000 | +188.0% | 9,767 | +11.5% | 0.01% | +175.0% |
Q1 2019 | $83,000 | +6.4% | 8,758 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $78,000 | -1.3% | 8,758 | +25.0% | 0.00% | 0.0% |
Q3 2018 | $79,000 | -12.2% | 7,008 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $90,000 | -14.3% | 7,008 | +12.6% | 0.00% | -20.0% |
Q1 2018 | $105,000 | +183.8% | 6,223 | +35.5% | 0.01% | +150.0% |
Q4 2017 | $37,000 | +42.3% | 4,591 | 0.0% | 0.00% | +100.0% |
Q3 2017 | $26,000 | -23.5% | 4,591 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $34,000 | – | 4,591 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |